Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapyPriya Rangan, Anna Mondino26 July 2022
NIR fluorescence imaging and treatment for cancer immunotherapyHoman Kang, Min-Woong Kang, Satoshi Kashiwagi, Hak Soo Choi20 July 2022
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospectsSolange Peters, Luis Paz-Ares, Roy S Herbst, Martin Reck20 July 2022
CD47/SIRPα axis: bridging innate and adaptive immunityAnneloes van Duijn, Sjoerd H Van der Burg, Ferenc A Scheeren13 July 2022
Lipid-loaded macrophages as new therapeutic target in cancerGiulia Marelli, Nicolò Morina, Federica Portale, Marta Pandini, Marta Iovino, Giusy Di Conza, Ping-Chih Ho, Diletta Di Mitri7 July 2022
Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?Roger Sun, Théophraste Henry, Adrien Laville, Alexandre Carré, Anthony Hamaoui, Sophie Bockel, Ines Chaffai, Antonin Levy, Cyrus Chargari, Charlotte Robert, Eric Deutsch6 July 2022
Vaccines for immunoprevention of DNA mismatch repair deficient cancersAlejandro Hernandez-Sanchez, Mark Grossman, Kevin Yeung, Shizuko S Sei, Steven Lipkin, Matthias Kloor22 June 2022
iRECIST and atypical patterns of response to immuno-oncology drugsJorge Luis Ramon-Patino, Sabine Schmid, Sally Lau, Lesley Seymour, Pierre-Olivier Gaudreau, Janice Juan Ning Li, Penelope Ann Bradbury, Emiliano Calvo17 June 2022
Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatmentLihong Wang, Louisa S Chard Dunmall, Zhenguo Cheng, Yaohe Wang31 May 2022
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cellsSainiteesh Maddineni, John L Silberstein, John B Sunwoo17 May 2022